UNG–RPA interaction governs the choice between high-fidelity and mutagenic uracil repair
Nucleic Acids Research · 05.05.2026 · 54 (9)
DOI: 10.1093/nar/gkag441 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 15.05.2026. Verfasst von Yunxiang Mu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX77054, United States. Hauptthemen laut MEDLINE: Uracil-DNA Glycosidase, Uracil, Excision Repair, DNA Repair. Die Arbeit nennt 83 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, MD Anderson, Texas Tobacco Settlement - Molecular Mechanisms of Tobacco Carcinogenesis.
Abstract (Originalsprache)
Mammalian uracil DNA glycosylase (UNG) removes uracils and initiates high-fidelity base excision repair to maintain genomic stability. During B cell development, activation-induced cytidine deaminase (AID) generates uracils in DNA, which UNG processes in an error-prone fashion to accomplish immunoglobulin (Ig) somatic hypermutation or class switch recombination (CSR). The mechanism that governs high-fidelity versus mutagenic uracil repair is not understood. The B cell tropic murine Gammaherpesvirus 68 (MHV68/MHV-4) encodes a functional homolog of UNG that can process AID-induced genomic uracils. MHV68UNG did not support hypermutation, suggesting intrinsic properties of UNG influence repair outcome. Noting the structural divergence between the UNGs, we define the RPA-interacting motif as a determinant of mutation outcome. UNG or RPA mutants unable to interact support only high-fidelity repair. In B cells, transversions at the Ig variable region are decreased, while CSR is supported. Thus UNG–RPA governs the generation of mutations and has implications for locus-specific mutagenesis in B cells and deamination-associated mutational signatures in cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX77054, United States.
- Department of Microbiology and Immunology, Stony Brook University, Stony Brook, NY 11794, United States.
- Molecular and Cellular Biology Program, Stony Brook University, Stony Brook, NY 11794, United States.
- HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, United States.
ORCID-Profile: Yunxiang Mu, Monika A Zelazowska, Laurie T Krug, Kevin M McBride
Förderung
- NIH HHS
- MD Anderson
- Texas Tobacco Settlement - Molecular Mechanisms of Tobacco Carcinogenesis
- NCI NIH HHS
- UTMDACC Center for Cancer Epigenetics
- Virginia Harris Cockrell Endowment Fund
- NIAID NIH HHS
- Recombinant Antibody Production Core
Zitieren
APA
Mu, Y., Chen, Z., Plummer, J. B., Zelazowska, M. A., Dong, Q., Krug, L. T., & McBride, K. M. (2026). UNG–RPA interaction governs the choice between high-fidelity and mutagenic uracil repair. Nucleic Acids Research, 54(9). https://doi.org/10.1093/nar/gkag441
Vancouver
Mu Y, Chen Z, Plummer JB, Zelazowska MA, Dong Q, Krug LT, et al. UNG–RPA interaction governs the choice between high-fidelity and mutagenic uracil repair. Nucleic Acids Research. 2026;54(9). doi:10.1093/nar/gkag441
BibTeX
@article{Mu2026,
author = {Mu, Yunxiang and Chen, Zaowen and Plummer, Joshua B and Zelazowska, Monika A and Dong, Qiwen and Krug, Laurie T and McBride, Kevin M},
title = {UNG–RPA interaction governs the choice between high-fidelity and mutagenic uracil repair},
journal = {Nucleic Acids Research},
year = {2026},
volume = {54},
number = {9},
doi = {10.1093/nar/gkag441}
}
EUVIMED